EXEL vs HRMY Stock Comparison
EXEL currently leads HRMY in this stock comparison, with AIQ scores of 82 vs 73. The clearest difference is momentum, while HRMY has the stronger value profile.
What is the main difference between EXEL and HRMY?
EXEL leads the current stock comparison as Exelixis, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Exelixis, Inc. vs Harmony Biosciences Holdings, Inc.
EXEL leads
EXEL leads by 9 AIQ points, primarily on Momentum and Risk Resilience, and the lead has widened from 0 points over 30 sessions. Wall Street currently favors HRMY on target upside.
Competitive: 4 of 6 evidence groups support EXEL, its lead is widening, and its current signal state is conflicted.
Exelixis, Inc.
Harmony Biosciences Holdings, Inc.
The Algovestiq AIQ Score currently favors EXEL over HRMY, 82 versus 73 as of Nov 15, 2026. EXEL's advantage is driven primarily by stronger momentum and risk resilience, while HRMY holds the stronger value profile. EXEL also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors HRMY. 4 of 6 covered evidence groups favor EXEL today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. EXEL lead: Strengthening — the AIQ differential moved from 0 to 9 points over 30 sessions.
Compare Exelixis, Inc. and Harmony Biosciences Holdings, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare EXEL and HRMY against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Momentum91 vs 66EXEL +25
- Risk Resilience77 vs 63EXEL +14
- Value79 vs 89HRMY +10
- Quality75 vs 77Even
4 of 6 evidence groups favor EXEL. EXEL’s edge is concentrated in momentum and risk resilience; HRMY keeps a meaningful value edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Value +1, not enough on its own to move the overall score.
No signal started or stopped since the prior session; its 6 active signals are unchanged.
Largest factor move: Quality +1, not enough on its own to move the overall score.
No signal started or stopped since the prior session; its 3 active signals are unchanged.
EXEL's lead was unchanged in the latest session.
Deeper signal detail for each name lives on its own signals page — EXEL and HRMY both carry a full feed there.
The central trade-off
EXEL (Exelixis, Inc.): the stronger current systematic profile, led by momentum and risk resilience.
HRMY (Harmony Biosciences Holdings, Inc.): the counter-case, on value, valuation, analyst expectations — but at materially higher volatility, 46.4% against 34.5%.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
EXELEXEL on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
EXELEXEL on combined revenue and EPS growth.
Value
HRMYHRMY on the peer-relative Value factor, by 10 points.
Momentum
EXELEXEL on the Momentum factor, by 25 points.
Lower downside
EXELEXEL on Risk Resilience, by 14 points.
Analyst upside
HRMYHRMY on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors EXEL, analyst targets favor HRMY. That disagreement is the most useful thing on this page.
| Measure | EXEL | HRMY | Note |
|---|---|---|---|
| Implied upside to target | -15% | +52.5% | HRMY has more room |
| Target dispersion | +23.9% | +35% | Lower is tighter analyst agreement |
| Consensus | Hold | Buy | Context, not a primary driver |
| Analysts covering | 17 | 12 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
4 of 6 covered evidence groups favor EXEL. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | EXEL | 82 vs 73 |
| Fundamentals | EXEL | revenue growth 4.8% vs 2.9%; EPS growth 3.5% vs -36.2%; TTM ROE 11.9% vs 4.5%; gross margin 96.3% vs 74%; operating margin 40.2% vs 22.2% |
| Valuation | HRMY | Value 79 vs 89 |
| Technicals | EXEL | Price vs 50-day 10.8% vs -12.6%; vs 200-day 32.1% vs -2.4% |
| Risk Resilience | EXEL | Risk Resilience 77 vs 63 |
| Analyst expectations | HRMY | Target upside -15% vs 52.5% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of EXEL and HRMY and are excluded from the count.
AIQ Decision Stability
The two are close enough that your objective, not the score, should decide.
- The AIQ gap is moderate at 9 points.
- The leader's advantage has been widening. (supports the conclusion holding)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on EXEL.
How the comparison changed
120 daily snapshots · May 27 – Nov 13EXEL lead: Strengthening — the AIQ differential moved from 0 to 9 points over 30 sessions.
- Today
- EXEL +9
- 82 vs 73
- 7 sessions ago
- EXEL +6
- 82 vs 76
- 30 sessions ago
- Level
- 80 vs 80
- 90 sessions ago
- Level
- 74 vs 74
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
3 bullish / 3 bearish, conflicted
Only EXEL
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Low Volume Rally Warning — bearish, volume, short horizon (0.54x)
- MACD Histogram Expanding Bearish — bearish, momentum, short horizon
- RSI Bearish Divergence — bearish, momentum, medium horizon
- Uptrend Structure Active — bullish, trend, long horizon
1 bullish / 0 bearish / 2 neutral
Only HRMY
- ADX Trend Strengthening — neutral, trend, medium horizon
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (4.79%)
Both carry 1 more signal that do not separate them: Golden Cross Active.
EXEL leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -1.2%, AIQ 0 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.12%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1HRMY closes the Momentum gap — currently 25 points behind, the largest single contributor to EXEL's edge.
- 2HRMY's ADX Trend Strengthening turns directional — it is neutral today and would confirm a change in trend.
- 3EXEL's conflicting signal state resolves bearish — it currently carries 3 bullish and 3 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
EXEL leads on balance| Metric | EXEL | HRMY |
|---|---|---|
| Revenue growth (YoY) | 4.8% | 2.9% |
| EPS growth (YoY) | 3.5% | -36.2% |
| Gross margin | 96.3% | 74% |
| Operating margin | 40.2% | 22.2% |
| Return on equity (TTM) | 11.9% | 4.5% |
| Debt to equity | 0.09 | 0.14 |
Performance
EXEL leads 5 of 6 windows| Metric | EXEL | HRMY |
|---|---|---|
| 1 week (5 sessions) | -0.8% | 2% |
| 1 month (20 sessions) | 10.9% | -11% |
| 3 months (63 sessions) | 31.9% | -11.5% |
| 6 months (126 sessions) | 37.6% | 12.2% |
| Year to date | 57.4% | -9.8% |
| 1 year (252 sessions) | 58.3% | 0.7% |
Technicals
EXEL has the stronger structure| Metric | EXEL | HRMY |
|---|---|---|
| RSI (14) | 58.6 | 36.4 |
| ADX (14) | 40.8 | 34.7 |
| Price vs 50-day | 10.8% | -12.6% |
| Price vs 200-day | 32.1% | -2.4% |
| Volatility (1M, annualized) | 34.5% | 46.4% |
Risk
EXEL is the more resilient| Metric | EXEL | HRMY |
|---|---|---|
| Beta | 0.61 | 0.63 |
| Sharpe ratio | 1.5 | 0.07 |
| Sortino ratio | 2.32 | 0.09 |
| Max drawdown | -12.6% | -34.5% |
| Current drawdown | -5.2% | -21.2% |
| Annualized volatility | 33.9% | 40.6% |
| Value at risk (95%) | -2.8% | -3.9% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, EXEL or HRMY?
On the Algovestiq AIQ Score, EXEL is the stronger of the two as of Nov 15, 2026, scoring 82 against HRMY's 73. The edge comes from momentum and risk resilience. HRMY is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is EXEL or HRMY the better buy right now?
EXEL carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 4 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.
Why does the AIQ Score favor EXEL over HRMY?
The composite weights Quality, Value, Momentum and Risk Resilience. EXEL leads Momentum by 25 points; EXEL leads Risk Resilience by 14 points; HRMY leads Value by 10 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, EXEL or HRMY?
Analyst price targets imply -15% upside for EXEL and +52.5% for HRMY, so the Street currently favors HRMY. That points the opposite way to the AIQ Score, which favors EXEL. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, EXEL or HRMY?
HRMY is the better-valued of the two on the peer-relative Value factor. HRMY on the peer-relative Value factor, by 10 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, EXEL or HRMY?
EXEL on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, EXEL or HRMY?
EXEL on the Momentum factor, by 25 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, EXEL or HRMY?
EXEL is the more resilient of the two, so the other name carries the higher downside risk. EXEL on Risk Resilience, by 14 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is EXEL more profitable than HRMY?
EXEL leads on the comparable margin measures — gross margin 96.3% vs 74%; operating margin 40.2% vs 22.2%; ttm roe 11.9% vs 4.5%.
Is EXEL's lead over HRMY getting stronger or weaker?
EXEL lead: Strengthening — the AIQ differential moved from 0 to 9 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.
What would change the EXEL vs HRMY verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: HRMY closes the Momentum gap — currently 25 points behind, the largest single contributor to EXEL's edge; HRMY's ADX Trend Strengthening turns directional — it is neutral today and would confirm a change in trend; EXEL's conflicting signal state resolves bearish — it currently carries 3 bullish and 3 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about EXEL and HRMY?
EXEL: 3 bullish / 3 bearish, conflicted. HRMY: 1 bullish / 0 bearish / 2 neutral. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on EXEL is Golden Cross Active (bullish, long horizon). On HRMY it is Golden Cross Active (bullish, long horizon).
Compare EXEL and HRMY with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.